Clinical Trial Update: Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride [Phase 3]

View source ↗

Summary

Phase 3 trial comparing liposomal bupivacaine versus bupivacaine hydrochloride for sternal wound infiltration in cardiac surgery has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis
• Mitral Valve Regurgitation
• Tricuspid Valve Regurgitation

Drugs mentioned

• Bupivacaine hydrochloride (bupivacaine hydrochloride)
• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Kathirvel Subramaniam | Conditions: Coronary Artery Disease, Coronary Artery Stenoses | Phase 3 | Status: COMPLETED | Results posted: 2021-09-05